You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

ALSUMA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Alsuma, and when can generic versions of Alsuma launch?

Alsuma is a drug marketed by Meridian Medcl and is included in one NDA. There is one patent protecting this drug.

This drug has four patent family members in four countries.

The generic ingredient in ALSUMA is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Alsuma

A generic version of ALSUMA was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.

  Try a Trial

Summary for ALSUMA
International Patents:4
US Patents:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 115
Patent Applications: 2,223
Formulation / Manufacturing:see details
DailyMed Link:ALSUMA at DailyMed
Drug patent expirations by year for ALSUMA
Anatomical Therapeutic Chemical (ATC) Classes for ALSUMA

US Patents and Regulatory Information for ALSUMA

ALSUMA is protected by one US patents.

Patents protecting ALSUMA

Autoinjector with needle depth adapter
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: ACUTE TREATMENT OF MIGRAINE ATTACKS, WITH OR WITHOUT AURA, AND THE TREATMENT OF CLUSTER HEADACHE EPISODES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl ALSUMA sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022377-001 Jun 29, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ALSUMA

See the table below for patents covering ALSUMA around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 2073866 AUTO-INJECTEUR AVEC ADAPTATEUR DE PROFONDEUR D'AIGUILLE (AUTOINJECTOR WITH NEEDLE DEPTH ADAPTER) ⤷  Try a Trial
Canada 2666860 AUTO-INJECTEUR AVEC ADAPTATEUR DE PROFONDEUR D'AIGUILLE (AUTOINJECTOR WITH NEEDLE DEPTH ADAPTER) ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2008048750 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.